Financial toxicity has been on the rise, but there has been movement toward reducing the burden through better communication and shared decision making, said Yousuf Zafar, MD, MHS, of the Duke Cancer Institute and a member of the Association of Community Cancer Centers Financial Advocacy Network Advisory Committee.
Financial toxicity has been on the rise, but there has been movement toward reducing the burden through better communication and shared decision making, said Yousuf Zafar, MD, MHS, of the Duke Cancer Institute and a member of the Association of Community Cancer Centers Financial Advocacy Network Advisory Committee.
Transcript
At what point after a cancer diagnosis do patients and families start to think about the financial costs?
The financial costs become an important part of the patient experience very early on. I think as soon as patients realize that their treatments are going to start, very soon after that, and in some cases even before that, they are exposed to their potential out-of-pocket costs. Which, for many people, can be in the range of thousands of dollars at a time. And those costs can be prohibitive to most patients.
How has financial toxicity changed over the last few years?
I think the trends that I have seen over time are concerning. And those trends in rising out-of-pocket costs and increasing financial toxicity for patients are due to a few points. First, cancer treatment is becoming more effective and more tolerable, which means more patients are on treatment for a longer period of time. Second, that treatment is expensive. And, third, because of the rising costs of drugs, in many cases, insurers are shifting more of that cost over to patients in the form of cost sharing. So, patients are on more expensive forms of treatment, for a longer period of time, and are shouldering a great proportion of that cost.
In turn, that financial toxicity, that out-of-pocket cost, is leading to nonadherence with medications, leading to patients spending their retirement savings, and in some cases selling their homes, and in a small number of cases, declaring personal bankruptcy.
Has a growing awareness of financial toxicity helped to change the trend so people can address it better?
I think we’re seeing some strong indications and movement toward reducing financial toxicity. Part of that has to do with good, early shared decision making between clinicians and patients. Strong conversations between clinicians and patients about not just the goals of treatment, but the potential cost that treatment might incur as well. And, in doing so, preparing patients for the likelihood that they’ll face out-of-pocket costs. And that preparation can actually go a long way.
Additionally, there are resources available for patients, in terms of financial assistance programs that, in some cases can be helpful. But, in all cases, I encourage patients often to communicate not just with their clinicians, but with their insurance companies to understand what, ultimately, will be covered.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
A Focus on Women: AUA Best Posters Highlight Female Athletes, Prenatal Care, and Women in Urology
May 9th 2024Three posters from the American Urological Association (AUA) 2024 Annual Meeting focused on urinary incontinence in female athletes, prenatal care for fetuses with spina bifida in California, and the experiences of women residents at the Brady Urological Institute.
Read More